Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrnaz Gharaee-Kermani

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Urology Reports|August 6, 2013
Promising molecular targets and biomarkers for male BPH and LUTSMehrnaz Gharaee-Kermani, Jill A Macoska
Methods in Molecular Medicine|August 25, 2005
Animal models of pulmonary fibrosisMehrnaz Gharaee-Kermani, Matthew Ullenbruch, Sem H Phan
Plos One|July 2, 2016
Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast PhenoconversionMehrnaz Gharaee-Kermani, Bethany B Moore, Jill A Macoska
The American Journal of Pathology|May 22, 2010
Epigenetic regulation of myofibroblast differentiation by DNA methylationBiao Hu, Mehrnaz Gharaee-Kermani, Zhe Wu, et al.
The American Journal of Pathology|March 26, 2011
Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosisBiao Hu, Mehrnaz Gharaee-Kermani, Zhe Wu, et al.
The American Journal of Pathology|May 28, 2005
Gender-based differences in bleomycin-induced pulmonary fibrosisMehrnaz Gharaee-Kermani, Kazuo Hatano, Yasuhiro Nozaki, et al.
Pharmaceutical Research|March 3, 2007
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapyMehrnaz Gharaee-Kermani, Margaret R Gyetko, Biao Hu, et al.
Plos One|October 6, 2022
The IL-4/IL-13 signaling axis promotes prostatic fibrosisQuentin D'Arcy, Mehrnaz Gharaee-Kermani, Alisa Zhilin-Roth, et al.
Expert Opinion on Investigational Drugs|May 22, 2008
The role of urokinase in idiopathic pulmonary fibrosis and implication for therapyMehrnaz Gharaee-Kermani, Biao Hu, Sem H Phan, et al.
Expert Opinion on Emerging Drugs|November 6, 2007
Current and emerging drugs for idiopathic pulmonary fibrosisMehrnaz Gharaee-Kermani, Biao Hu, Victor J Thannickal, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Urology Reports|August 6, 2013
Promising molecular targets and biomarkers for male BPH and LUTSMehrnaz Gharaee-Kermani, Jill A Macoska
Methods in Molecular Medicine|August 25, 2005
Animal models of pulmonary fibrosisMehrnaz Gharaee-Kermani, Matthew Ullenbruch, Sem H Phan
Plos One|July 2, 2016
Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast PhenoconversionMehrnaz Gharaee-Kermani, Bethany B Moore, Jill A Macoska
The American Journal of Pathology|May 22, 2010
Epigenetic regulation of myofibroblast differentiation by DNA methylationBiao Hu, Mehrnaz Gharaee-Kermani, Zhe Wu, et al.
The American Journal of Pathology|March 26, 2011
Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosisBiao Hu, Mehrnaz Gharaee-Kermani, Zhe Wu, et al.
The American Journal of Pathology|May 28, 2005
Gender-based differences in bleomycin-induced pulmonary fibrosisMehrnaz Gharaee-Kermani, Kazuo Hatano, Yasuhiro Nozaki, et al.
Pharmaceutical Research|March 3, 2007
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapyMehrnaz Gharaee-Kermani, Margaret R Gyetko, Biao Hu, et al.
Plos One|October 6, 2022
The IL-4/IL-13 signaling axis promotes prostatic fibrosisQuentin D'Arcy, Mehrnaz Gharaee-Kermani, Alisa Zhilin-Roth, et al.
Expert Opinion on Investigational Drugs|May 22, 2008
The role of urokinase in idiopathic pulmonary fibrosis and implication for therapyMehrnaz Gharaee-Kermani, Biao Hu, Sem H Phan, et al.
Expert Opinion on Emerging Drugs|November 6, 2007
Current and emerging drugs for idiopathic pulmonary fibrosisMehrnaz Gharaee-Kermani, Biao Hu, Victor J Thannickal, et al.
Pageof 6